{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T00:36:00Z","timestamp":1774571760007,"version":"3.50.1"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2019,8,21]],"date-time":"2019-08-21T00:00:00Z","timestamp":1566345600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2019,8,21]],"date-time":"2019-08-21T00:00:00Z","timestamp":1566345600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Pharmacokinet"],"published-print":{"date-parts":[[2020,2]]},"DOI":"10.1007\/s40262-019-00811-y","type":"journal-article","created":{"date-parts":[[2019,8,21]],"date-time":"2019-08-21T04:46:18Z","timestamp":1566362778000},"page":"257-264","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Population Pharmacokinetics of Intravenous Salbutamol in Children with Refractory Status Asthmaticus"],"prefix":"10.1007","volume":"59","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1276-0157","authenticated-orcid":false,"given":"Nienke J.","family":"Vet","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brenda C. M.","family":"de Winter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Muriel","family":"Koninckx","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shelley A.","family":"Boeschoten","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Annemie L. M.","family":"Boehmer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jacintha T.","family":"Verhallen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frans B.","family":"Pl\u00f6tz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anja A.","family":"Vaessen-Verberne","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bart C. H.","family":"van der Nagel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Catherijne A. J.","family":"Knibbe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Corinne M. P.","family":"Buysse","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saskia N.","family":"de Wildt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Birgit C. P.","family":"Koch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthijs","family":"de Hoog","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,8,21]]},"reference":[{"key":"811_CR1","doi-asserted-by":"publisher","first-page":"e904","DOI":"10.1542\/peds.2009-3239","volume":"126","author":"ME Hartman","year":"2010","unstructured":"Hartman ME, Linde-Zwirble WT, Angus DC, Watson RS. Trends in admissions for pediatric status asthmaticus in New Jersey over a 15-year period. Pediatrics. 2010;126:e904\u201311.","journal-title":"Pediatrics."},{"issue":"7","key":"811_CR2","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1002\/ppul.24009","volume":"53","author":"SA Boeschoten","year":"2018","unstructured":"Boeschoten SA, Buysse CMP, Merkus P, van Wijngaarden JMC, Heisterkamp SGJ, de Jongste JC, SKIC Dutch Collaborative PICU Research Network, et al. Children with severe acute asthma admitted to Dutch PICUs: a changing landscape. Pediatr Pulmonol. 2018;53(7):857\u201365.","journal-title":"Pediatr Pulmonol."},{"key":"811_CR3","unstructured":"British guideline on the management of asthma: a national clinical guideline. 2016. Available at: https:\/\/www.brit-thoracic.org.uk\/document-library\/clinical-information\/asthma\/btssign-asthma-guideline-2016\/ ."},{"key":"811_CR4","doi-asserted-by":"publisher","first-page":"849","DOI":"10.4187\/respcare.05174","volume":"62","author":"KJ Rehder","year":"2017","unstructured":"Rehder KJ. Adjunct therapies for refractory status asthmaticus in children. Respir Care. 2017;62:849\u201365.","journal-title":"Respir Care."},{"key":"811_CR5","doi-asserted-by":"crossref","unstructured":"Travers AH, Milan SJ, Jones AP, Camargo CA Jr, Rowe BH. Addition of intravenous beta(2)-agonists to inhaled beta(2)-agonists for acute asthma. Cochrane Database Syst Rev. 2012;(12):CD010179.","DOI":"10.1002\/14651858.CD010179"},{"key":"811_CR6","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1111\/j.1365-2125.1996.tb00156.x","volume":"41","author":"DW Boulton","year":"1996","unstructured":"Boulton DW, Fawcett JP. Enantioselective disposition of salbutamol in man following oral and intravenous administration. Br J Clin Pharmacol. 1996;41:35\u201340.","journal-title":"Br J Clin Pharmacol."},{"key":"811_CR7","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1016\/j.pupt.2006.05.003","volume":"20","author":"G Maier","year":"2007","unstructured":"Maier G, Rubino C, Hsu R, Grasela T, Baumgartner RA. Population pharmacokinetics of (R)-albuterol and (S)-albuterol in pediatric patients aged 4-11\u00a0years with asthma. Pulm Pharmacol Ther. 2007;20:534\u201342.","journal-title":"Pulm Pharmacol Ther."},{"key":"811_CR8","doi-asserted-by":"publisher","first-page":"23","DOI":"10.2165\/00003088-200140010-00003","volume":"40","author":"DW Boulton","year":"2001","unstructured":"Boulton DW, Fawcett JP. The pharmacokinetics of levosalbutamol: what are the clinical implications? Clin Pharmacokinet. 2001;40:23\u201340.","journal-title":"Clin Pharmacokinet."},{"key":"811_CR9","doi-asserted-by":"publisher","first-page":"2179","DOI":"10.1097\/00003246-200006000-00118","volume":"28","author":"F Shann","year":"2000","unstructured":"Shann F. Dose of intravenous infusions of terbutaline and salbutamol. Crit Care Med. 2000;28:2179\u201380.","journal-title":"Crit Care Med."},{"key":"811_CR10","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1046\/j.1365-2044.2003.03092.x","volume":"58","author":"WF Sellers","year":"2003","unstructured":"Sellers WF, Messahel B. Rapidly repeated intravenous boluses of salbutamol for acute severe asthma. Anaesthesia. 2003;58:680\u20133.","journal-title":"Anaesthesia."},{"key":"811_CR11","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1136\/archdischild-2013-304467","volume":"99","author":"ES Starkey","year":"2014","unstructured":"Starkey ES, Mulla H, Sammons HM, Pandya HC. Intravenous salbutamol for childhood asthma: evidence-based medicine? Arch Dis Child. 2014;99:873\u20137.","journal-title":"Arch Dis Child."},{"key":"811_CR12","doi-asserted-by":"publisher","first-page":"1030","DOI":"10.1056\/NEJM199810083391503","volume":"339","author":"F Qureshi","year":"1998","unstructured":"Qureshi F, Pestian J, Davis P, Zaritsky A. Effect of nebulized ipratropium on the hospitalization rates of children with asthma. N Engl J Med. 1998;339:1030\u20135.","journal-title":"N Engl J Med."},{"key":"811_CR13","doi-asserted-by":"publisher","first-page":"e0157724","DOI":"10.1371\/journal.pone.0157724","volume":"11","author":"H Eggink","year":"2016","unstructured":"Eggink H, Brand P, Reimink R, Bekhof J. Clinical scores for dyspnoea severity in children: a prospective validation study. PLoS One. 2016;11:e0157724.","journal-title":"PLoS One."},{"key":"811_CR14","doi-asserted-by":"publisher","first-page":"e50","DOI":"10.1038\/psp.2013.24","volume":"2","author":"RJ Keizer","year":"2013","unstructured":"Keizer RJ, Karlsson MO, Hooker A. Modeling and simulation workbench for NONMEM: tutorial on Pirana, PsN, and Xpose. CPT Pharmacometrics Syst Pharmacol. 2013;2:e50.","journal-title":"CPT Pharmacometrics Syst Pharmacol."},{"key":"811_CR15","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.3109\/03602538409033558","volume":"15","author":"H Boxenbaum","year":"1984","unstructured":"Boxenbaum H. Interspecies pharmacokinetic scaling and the evolutionary-comparative paradigm. Drug Metab Rev. 1984;15:1071\u2013121.","journal-title":"Drug Metab Rev."},{"key":"811_CR16","unstructured":"de Winter B, de Hoog M, Vet NJ, Dunk-Craaijo J, Koch BCP, de Wildt SN. High albuterol plasma concentrations caused by fingerprick blood following inhalation on the ICU [abstract]. In: 14th international congress of therapeutic drug monitoring and clinical toxicology; 11\u201315 Oct 2015: Rotterdam."},{"key":"811_CR17","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1136\/archdischild-2014-306591","volume":"100","author":"MD Lyttle","year":"2015","unstructured":"Lyttle MD, O\u2019Sullivan R, Doull I, Hartshorn S, Morris I, Powell CV. Variation in treatment of acute childhood wheeze in emergency departments of the United Kingdom and Ireland: an international survey of clinician practice. Arch Dis Child. 2015;100:121\u20135.","journal-title":"Arch Dis Child."},{"key":"811_CR18","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1183\/09031936.93.05010080","volume":"5","author":"C Janson","year":"1992","unstructured":"Janson C, Boe J, Boman G, Mossberg B, Svedmyr N. Bronchodilator intake and plasma levels on admission for severe acute asthma. Eur Respir J. 1992;5:80\u20135.","journal-title":"Eur Respir J."},{"key":"811_CR19","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1007\/s00228-010-0787-4","volume":"66","author":"ET Rotta","year":"2010","unstructured":"Rotta ET, Amantea SL, Froehlich PE, Becker A. Plasma concentrations of salbutamol in the treatment of acute asthma in a pediatric emergency. Could age be a parameter of influence? Eur J Clin Pharmacol. 2010;66:605\u201310.","journal-title":"Eur J Clin Pharmacol."},{"key":"811_CR20","doi-asserted-by":"publisher","first-page":"466P","DOI":"10.1111\/j.1476-5381.1971.tb07200.x","volume":"43","author":"ME Evans","year":"1971","unstructured":"Evans ME, Paterson JW, Richards AJ, Walker SR. Pharmacokinetics of inhaled salbutamol in asthmatic patients. Br J Pharmacol. 1971;43:466P\u20137P.","journal-title":"Br J Pharmacol."},{"key":"811_CR21","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1023\/A:1009935116877","volume":"15","author":"R Regenthal","year":"1999","unstructured":"Regenthal R, Krueger M, Koeppel C, Preiss R. Drug levels: therapeutic and toxic serum\/plasma concentrations of common drugs. J Clin Monit Comput. 1999;15:529\u201344.","journal-title":"J Clin Monit Comput."},{"key":"811_CR22","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1111\/j.1651-2227.1993.tb12609.x","volume":"82","author":"AC Penna","year":"1993","unstructured":"Penna AC, Dawson KP, Manglick P, Tam J. Systemic absorption of salbutamol following nebulizer delivery in acute asthma. Acta Paediatr. 1993;82:963\u20136.","journal-title":"Acta Paediatr."},{"key":"811_CR23","doi-asserted-by":"publisher","first-page":"892","DOI":"10.1097\/00003246-198410000-00012","volume":"12","author":"D Bohn","year":"1984","unstructured":"Bohn D, Kalloghlian A, Jenkins J, Edmonds J, Barker G. Intravenous salbutamol in the treatment of status asthmaticus in children. Crit Care Med. 1984;12:892\u20136.","journal-title":"Crit Care Med."},{"key":"811_CR24","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1016\/S0140-6736(96)06358-1","volume":"349","author":"GJ Browne","year":"1997","unstructured":"Browne GJ, Penna AS, Phung X, Soo M. Randomised trial of intravenous salbutamol in early management of acute severe asthma in children. Lancet. 1997;349:301\u20135.","journal-title":"Lancet."},{"key":"811_CR25","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1097\/00003246-200202000-00030","volume":"30","author":"GJ Browne","year":"2002","unstructured":"Browne GJ, Trieu L, Van Asperen P. Randomized, double-blind, placebo-controlled trial of intravenous salbutamol and nebulized ipratropium bromide in early management of severe acute asthma in children presenting to an emergency department. Crit Care Med. 2002;30:448\u201353.","journal-title":"Crit Care Med."},{"key":"811_CR26","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1016\/j.jaci.2005.04.013","volume":"116","author":"WR Henderson Jr","year":"2005","unstructured":"Henderson WR Jr, Banerjee ER, Chi EY. Differential effects of (S)- and (R)-enantiomers of albuterol in a mouse asthma model. J Allergy Clin Immunol. 2005;116:332\u201340.","journal-title":"J Allergy Clin Immunol."},{"key":"811_CR27","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1002\/ppul.20223","volume":"40","author":"A Auais","year":"2005","unstructured":"Auais A, Wedde-Beer K, Piedimonte G. Anti-inflammatory effect of albuterol enantiomers during respiratory syncytial virus infection in rats. Pediatr Pulmonol. 2005;40:228\u201334.","journal-title":"Pediatr Pulmonol."},{"key":"811_CR28","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1016\/j.jaci.2003.12.039","volume":"113","author":"DK Agrawal","year":"2004","unstructured":"Agrawal DK, Ariyarathna K, Kelbe PW. (S)-albuterol activates pro-constrictory and pro-inflammatory pathways in human bronchial smooth muscle cells. J Allergy Clin Immunol. 2004;113:503\u201310.","journal-title":"J Allergy Clin Immunol."},{"key":"811_CR29","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1016\/j.ajem.2006.01.027","volume":"24","author":"R Nowak","year":"2006","unstructured":"Nowak R, Emerman C, Hanraban JP, Parsey MV, Hanania NA, Claus R, et al. A comparison of levalbuterol with racemic albuterol in the treatment of acute severe asthma exacerbations in adults. Am J Emerg Med. 2006;24:259\u201367.","journal-title":"Am J Emerg Med."},{"key":"811_CR30","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1164\/rccm.2606003","volume":"9","author":"PJ Barnes","year":"2006","unstructured":"Barnes PJ. Treatment with (R)-albuterol has no advantage over racemic albuterol. Am J Resp Crit Care Med. 2006;9:969\u201372.","journal-title":"Am J Resp Crit Care Med."}],"container-title":["Clinical Pharmacokinetics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40262-019-00811-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40262-019-00811-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40262-019-00811-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,19]],"date-time":"2023-09-19T09:08:22Z","timestamp":1695114502000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s40262-019-00811-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8,21]]},"references-count":30,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020,2]]}},"alternative-id":["811"],"URL":"https:\/\/doi.org\/10.1007\/s40262-019-00811-y","relation":{},"ISSN":["0312-5963","1179-1926"],"issn-type":[{"value":"0312-5963","type":"print"},{"value":"1179-1926","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,8,21]]},"assertion":[{"value":"21 August 2019","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"No external funding was used in the preparation of this manuscript.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"Nienke J. Vet, Brenda C.M. de Winter, Muriel Koninckx, Shelley A. Boeschoten, Annemie L.M. Boehmer, Jacintha T. Verhallen, Frans B. Pl\u00f6tz, Anja A. Vaessen-Verberne, Bart C.H. van der Nagel, Catherijne A.J. Knibbe, Corinne M.P. Buysse, Saskia N. de Wildt, Birgit C.P. Koch, and Matthijs de Hoog declare they have no potential conflicts of interest that might be relevant to the contents of this manuscript.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}